NCT01827267 2018-07-03Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung CancerPuma Biotechnology, Inc.Phase 2 Completed62 enrolled 12 charts
NCT00921310 2016-12-13Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung CancerWashington University School of MedicinePhase 1/2 Terminated12 enrolled 11 charts